Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma (MEMMAT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Medical University of Vienna
Sponsor:
Information provided by (Responsible Party):
Andreas Peyrl, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01356290
First received: May 17, 2011
Last updated: June 27, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2022
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)